Ashraf Attia is a chief executive officer at Bionic Vision Technologies and Non-Executive Director on the board of ASX-listed Company DorsaVi . Prior to BVT, Ash held the position of Vice President Asia Pacific, the Middle East and Israel, at TransMedics Inc. Ash also held Vice President and Managing Director roles within several other major Australian and International medtech organizations such as Thoratec, St Jude Medical, Micromed, Syncardia, Ventracor, Biotronik, SulzerMedica and Telectronics.  He is also a Fellow of the Australian Institute of Company Directors.